KALA BIO, INC. Line of Credit Facility, Maximum Borrowing Capacity
KALA BIO, INC. (KALA) had Line of Credit Facility, Maximum Borrowing Capacity of $10.00 million as of 2017-09-28, per its 10-K filed 2018-04-02.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2018-04-02
- 2017-09-28: Line of Credit Facility, Maximum Borrowing Capacity $10.00M.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2017-09-28 | $10.00M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |